At Photon Biosciences, our vision is a world where people have access to Dx and preventative testing anytime, anywhere and be able to make decisions to take control of their health on the go.
The technologies that we bring together in our PBSDX platform is to ensure that we achieve this end goal.
We are developing a robust portfolio of human and veterinary diagnostic tests internally and collaborate with commercial, academic and government partners
Heart failure (HF) is the end result of cardiac and non-cardiac abnormalities leading to a complex clinical diagnosis with multiple phenotypes. In 2018, HF was mentioned on 379,800 death certificates (13.4F%). Quick, accurate diagnosis and prompt treatment is essential as each 30 minutes of delay increases the relative risk of 1-year mortality by 7.5% in patients with AMI. Our PBSDx based HF Multiplex Test PBSHeartSafe is cost effective and allow accurate measurements with predictive capability
Among all transfusable blood products, platelets carry the highest risk for causing transfusion-related sepsis. According to the FDA, microbial contamination was the third highest cause of transfusion-associated fatalities. Our PBSDxTM based automated test (PBSBactiSafe) has better sensitivity and will have the convenience of using at various settings.
PBSDx Multiplex Point-of-Solution diagnostic offerings will give veterinarians new choice to deliver comprehensive healthcare for companion animals faster and economically than previously possible.